Kratom, a plant from Southeast Asia, has been a subject of controversy in the United States since its introduction after the ...
Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...
The U.S. Food and Drug Administration upgraded the classification of recalled broccoli sold at Walmart originally issued in ...
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...
Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
Vaccines do not cause autism. You’ve almost certainly read that before — but often without a full explanation of how we know ...
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
If passed, the Illinois Food Safety Act would ban certain additives in candy, soda, and other food items sold and ...
Cal Yee Farms is recalling several of its popular chocolate treats due to a labeling mistake that could be deadly for people with food allergies.
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...